Open AccessANALYSIS OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS DURING 20142016
Author(s) -
В. В. Агинова,
Н. В. Дмитриева,
И. Н. Петухова,
З. В. Григорьевская,
Н. С. Багирова,
И. В. Терещенко,
С. А. Дьякова,
Т. А. Калинчук,
А. И. Дмитриева,
В. Д. Винникова
Publication year - 2019
Publication title -
sibirskij onkologičeskij žurnal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.115
H-Index - 4
eISSN - 2312-3168
pISSN - 1814-4861
DOI - 10.21294/1814-4861-2019-18-4-43-49
Subject(s) - medicine , acinetobacter baumannii , cancer , pseudomonas aeruginosa , klebsiella pneumoniae , staphylococcus aureus , enterococcus , lung cancer , acinetobacter , microbiology and biotechnology , antibiotics , bacteria , biology , biochemistry , genetics , escherichia coli , gene
The purpose of the study was to analyze infectious complications caused by multi-drug-resistant organisms depending on anticancer therapy. Material and Methods . A total of 229 cancer patients with infectious complications of cancer therapy were included into the study. Results . Lung cancer was the most predominant cancer (26.6 %) followed by gastric cancer (25.3 %) and esophageal cancer (14.4 %). Infectious complications occurring after surgery were observed in 83.4 % of the patients. Infectious complications caused by Acinetobacter baumannii were the most common (40.6 %), followed by Klebsiella pneumoniae (28.5 %), Pseudomonas aeruginosa (19.5 %), Staphylococcus spp. (9.4 %), and Enterococcus spp. (1.8 %). Conclusion . Infectious complications occurred more frequently in postoperative cancer patients (p<0.02), and the ESKAPE group pathogens were the leading cause of these infections.